176 related articles for article (PubMed ID: 11473043)
1. Treatment of type 2 diabetes by adenoviral-mediated overexpression of the glucokinase regulatory protein.
Slosberg ED; Desai UJ; Fanelli B; St Denny I; Connelly S; Kaleko M; Boettcher BR; Caplan SL
Diabetes; 2001 Aug; 50(8):1813-20. PubMed ID: 11473043
[TBL] [Abstract][Full Text] [Related]
2. Mice mutant for glucokinase regulatory protein exhibit decreased liver glucokinase: a sequestration mechanism in metabolic regulation.
Farrelly D; Brown KS; Tieman A; Ren J; Lira SA; Hagan D; Gregg R; Mookhtiar KA; Hariharan N
Proc Natl Acad Sci U S A; 1999 Dec; 96(25):14511-6. PubMed ID: 10588736
[TBL] [Abstract][Full Text] [Related]
3. An allosteric activator of glucokinase impairs the interaction of glucokinase and glucokinase regulatory protein and regulates glucose metabolism.
Futamura M; Hosaka H; Kadotani A; Shimazaki H; Sasaki K; Ohyama S; Nishimura T; Eiki J; Nagata Y
J Biol Chem; 2006 Dec; 281(49):37668-74. PubMed ID: 17028192
[TBL] [Abstract][Full Text] [Related]
4. Antidiabetic effects of glucokinase regulatory protein small-molecule disruptors.
Lloyd DJ; St Jean DJ; Kurzeja RJ; Wahl RC; Michelsen K; Cupples R; Chen M; Wu J; Sivits G; Helmering J; Komorowski R; Ashton KS; Pennington LD; Fotsch C; Vazir M; Chen K; Chmait S; Zhang J; Liu L; Norman MH; Andrews KL; Bartberger MD; Van G; Galbreath EJ; Vonderfecht SL; Wang M; Jordan SR; Véniant MM; Hale C
Nature; 2013 Dec; 504(7480):437-40. PubMed ID: 24226772
[TBL] [Abstract][Full Text] [Related]
5. Insulin-receptor substrate-2 (irs-2) is required for maintaining glucokinase and glucokinase regulatory protein expression in mouse liver.
Roncero I; Alvarez E; Acosta C; Sanz C; Barrio P; Hurtado-Carneiro V; Burks D; Blázquez E
PLoS One; 2013; 8(4):e58797. PubMed ID: 23560040
[TBL] [Abstract][Full Text] [Related]
6. Acetylation of glucokinase regulatory protein decreases glucose metabolism by suppressing glucokinase activity.
Park JM; Kim TH; Jo SH; Kim MY; Ahn YH
Sci Rep; 2015 Dec; 5():17395. PubMed ID: 26620281
[TBL] [Abstract][Full Text] [Related]
7. Phenotypic correction of diabetic mice by adenovirus-mediated glucokinase expression.
Desai UJ; Slosberg ED; Boettcher BR; Caplan SL; Fanelli B; Stephan Z; Gunther VJ; Kaleko M; Connelly S
Diabetes; 2001 Oct; 50(10):2287-95. PubMed ID: 11574410
[TBL] [Abstract][Full Text] [Related]
8. Characterization of glucokinase regulatory protein-deficient mice.
Grimsby J; Coffey JW; Dvorozniak MT; Magram J; Li G; Matschinsky FM; Shiota C; Kaur S; Magnuson MA; Grippo JF
J Biol Chem; 2000 Mar; 275(11):7826-31. PubMed ID: 10713097
[TBL] [Abstract][Full Text] [Related]
9. Discovery of Small-Molecule Glucokinase Regulatory Protein Modulators That Restore Glucokinase Activity.
Chen K; Michelsen K; Kurzeja RJ; Han J; Vazir M; St Jean DJ; Hale C; Wahl RC
J Biomol Screen; 2014 Aug; 19(7):1014-23. PubMed ID: 24717911
[TBL] [Abstract][Full Text] [Related]
10. Recent Updates on Glucokinase Activators and Glucokinase Regulatory Protein Disrupters for the Treatment of Type 2 Diabetes Mellitus.
Kaushik A; Kaushik M
Curr Diabetes Rev; 2019; 15(3):205-212. PubMed ID: 30039763
[TBL] [Abstract][Full Text] [Related]
11. Molecular basis for the role of glucokinase regulatory protein as the allosteric switch for glucokinase.
Choi JM; Seo MH; Kyeong HH; Kim E; Kim HS
Proc Natl Acad Sci U S A; 2013 Jun; 110(25):10171-6. PubMed ID: 23733961
[TBL] [Abstract][Full Text] [Related]
12. The role of the regulatory protein of glucokinase in the glucose sensory mechanism of the hepatocyte.
de la Iglesia N; Mukhtar M; Seoane J; Guinovart JJ; Agius L
J Biol Chem; 2000 Apr; 275(14):10597-603. PubMed ID: 10744755
[TBL] [Abstract][Full Text] [Related]
13. Glucose toxicity is responsible for the development of impaired regulation of endogenous glucose production and hepatic glucokinase in Zucker diabetic fatty rats.
Fujimoto Y; Torres TP; Donahue EP; Shiota M
Diabetes; 2006 Sep; 55(9):2479-90. PubMed ID: 16936196
[TBL] [Abstract][Full Text] [Related]
14. Berberine alleviates hyperglycemia by targeting hepatic glucokinase in diabetic db/db mice.
Li M; Dang Y; Li Q; Zhou W; Zuo J; Yao Z; Zhang L; Ji G
Sci Rep; 2019 May; 9(1):8003. PubMed ID: 31142783
[TBL] [Abstract][Full Text] [Related]
15. Glucokinase regulatory protein is essential for the proper subcellular localisation of liver glucokinase.
de la Iglesia N; Veiga-da-Cunha M; Van Schaftingen E; Guinovart JJ; Ferrer JC
FEBS Lett; 1999 Aug; 456(2):332-8. PubMed ID: 10456334
[TBL] [Abstract][Full Text] [Related]
16. Lack of glucokinase regulatory protein expression may contribute to low glucokinase activity in feline liver.
Hiskett EK; Suwitheechon OU; Lindbloom-Hawley S; Boyle DL; Schermerhorn T
Vet Res Commun; 2009 Mar; 33(3):227-40. PubMed ID: 18780155
[TBL] [Abstract][Full Text] [Related]
17. Allosteric activators of glucokinase: potential role in diabetes therapy.
Grimsby J; Sarabu R; Corbett WL; Haynes NE; Bizzarro FT; Coffey JW; Guertin KR; Hilliard DW; Kester RF; Mahaney PE; Marcus L; Qi L; Spence CL; Tengi J; Magnuson MA; Chu CA; Dvorozniak MT; Matschinsky FM; Grippo JF
Science; 2003 Jul; 301(5631):370-3. PubMed ID: 12869762
[TBL] [Abstract][Full Text] [Related]
18. Cellular characterisation of the GCKR P446L variant associated with type 2 diabetes risk.
Rees MG; Wincovitch S; Schultz J; Waterstradt R; Beer NL; Baltrusch S; Collins FS; Gloyn AL
Diabetologia; 2012 Jan; 55(1):114-22. PubMed ID: 22038520
[TBL] [Abstract][Full Text] [Related]
19. Metabolic impact of glucokinase overexpression in liver: lowering of blood glucose in fed rats is accompanied by hyperlipidemia.
O'Doherty RM; Lehman DL; Télémaque-Potts S; Newgard CB
Diabetes; 1999 Oct; 48(10):2022-7. PubMed ID: 10512368
[TBL] [Abstract][Full Text] [Related]
20. Stimulation of hepatocyte glucose metabolism by novel small molecule glucokinase activators.
Brocklehurst KJ; Payne VA; Davies RA; Carroll D; Vertigan HL; Wightman HJ; Aiston S; Waddell ID; Leighton B; Coghlan MP; Agius L
Diabetes; 2004 Mar; 53(3):535-41. PubMed ID: 14988235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
